手機掃碼訪問本站
微信咨詢
猜你喜歡
- 59-05-2 / 甲氨蝶呤治療類風關的跌宕歷程
- 5-[(4-氯-3,5-二甲基苯氧基)甲基]-4-甲基-4H-1,2,4-噻唑-3-硫醇
- Oleyl Mesylate
- 磷酸氫鈉銨
- 3-氨-3-(1-萘基)丙酸
- 50-21-5/乳酸性酸中毒
- 碳酸氫鉀
- 4-(N-Acetyl)piperidinyl 2-(5-Methoxy)phenol Ketone
- (7ALPHA,17ALPHA)-19-氫過氧基-17-羥基-7-甲基-19-去甲孕甾-4-烯-20-炔-3-酮
- 6-氨基青霉烷酸
- Methyl 2-O-Methyl-3,4-O-(1-methylethylidene)-a-D-galactopyranoside
- 6-氟-2-甲基喹啉
- 二乙基甲基乙烯基硅烷
- 103-90-2 / 必理通的作用機制及臨床特點
- 2-芐硫基-4-氨基-6-羥基嘧啶
- 4-[[3-(4-甲基苯基)-3-氧代-1-(三氟甲基)亞丙基]氨基]苯磺酰胺
- 10-(3-氯-2-甲基丙基)-2-甲氧基-10H-吩噻嗪
- ethyl 8-allyl-5-hydroxy-2-(methylthio)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylate
- 1306-38-3 / 氧化鈰
- 51803-78-2 / 尼美舒利分散片的功效
- 1478-61-1/六氟雙酚 A的制備
- 5-氟-2-甲氧基苯硼酸
- 2-(乙烷磺酰)乙醇
- 3-BROMOMETHYL-3-[6-(4-CHLOROPHENOXYL)-HEXYL]-TETRAHYDROPYRROLO[2,1-C] [1,4]OXAZINE-1,4-DIONE
- 1-(Thieno[3,2-d]pyrimidin-4-yl)piperidine-4-carboxaldehyde
